TRG CLONALITY INTERROGATION BY CE AND NGS: BRIDGING THE GAP BETWEEN CLASSICAL AND LEADING EDGE TECHNOLOGIES

EHA Library, Kasey Hutt, 293826

WHOLE GENOME ANALYSIS REVEALS POTENTIAL MICRO-RNA'S FOR P53-ASSOCIATED REGULATION OF PDL1 IN B- AND T-CELL LYMPHOMAS

EHA Library, Georgia Kokaraki, 293828

BASELINE AMOUNT OF IMMUNOGLOBULIN M CAN IDENTIFY PATIENTS WITH POOR OUTCOME: RESULTS FROM A REAL-LIFE SINGLE-CENTER STUDY IN HODGKIN LYMPHOMA

EHA Library, ALESSANDRA ROMANO, 293829

COMBINATION OF TAFASITAMAB (MOR208) AND LENALIDOMIDE ENHANCES TUMOR CELL DEATH OF B-CELL LYMPHOMA IN VITRO

EHA Library, Maria Patra, 293830

THE NPM-ALK ONCOGENIC KINASE ACTIVATES THE C-GAS-STING PATHWAY IN ANAPLASTIC LARGE CELL LYMPHOMA (ALCL)

EHA Library, Jingjing Ye, 293831

MOLECULAR CHARACTERIZATION OF FOXO1 MUTATIONS IN NON-HODGKIN LYMPHOMA

EHA Library, Ariane Sablon, 293832

ANTI-ANGIOGENIC THERAPY WITH BEVACIZUMAB IS EFFECTIVE IN VIVO IN IBRUTINIB-RESISTANT MANTLE CELL LYMPHOMA

EHA Library, Petra Vockova, 293833

TMEM244 GENE IS ECTOPICALLY EXPRESSED IN SÉZARY CELLS DUE TO HYPOMETHYLATION OF ITS PROMOTER

EHA Library, Karolina Rassek, 293834

PD-L1/PD-L2 GENOMIC IMBALANCES IN CLASSICAL HODGKIN LYMPHOMA. ANALYSIS OF BOTH REED-STERNBERG/HODGKIN AND TUMOR MICROENVIRONMENT CELLS. ARGENTINIAN EXPERIENCE.

EHA Library, Mauro García-Montenegro, 293835

PRODUCTS OF EBV-POSITIVE NEOPLASTIC NK-CELLS INDUCE DIFFERENTIATION INTO MACROPHAGES AND PROCOAGULANT ACTIVITY OF MONOCYTES, WHICH LEADS TO HLH

EHA Library, Mayumi Yoshimori, 293836

CYTOKINE EXPRESSION COULD IDENTIFY DIFFERENT PROFILES COMPARING HISTOLOGICAL GRADE IN FOLLICULAR LYMPHOMA. PRELIMINARY RESULTS.

EHA Library, Santiago Mercadal, 293837

LOW PERCENTAGE OF T LYMPHOCYTES IN HODGKIN´S LYMPHOMA LYMPH NODES, MEASURED BY FLOW CYTOMETRY, HAS AN ADVERSE IMPACT ON PROGRESSION FREE SURVIVAL REGARDLESS OF NEGATIVE INTERIM PET SCAN STATUS.

EHA Library, Laura Korin, 293838

PRESENCE OF INNATE LYMPHOID CELLS IN ALLOGENEIC HEMATOPOIETIC CELL GRAFTS CORRELATES WITH REDUCED GRAFT VERSUS HOST DISEASE

EHA Library, Myrddin Verheij, 293839

ENDOTHELIAL MICROPARTICLES-MEDIATED TRANSFER OF LNCRNA NEAT1 PROMOTES THE INITIATION OF ACUTE GVHD AFTER ALLO-HSCT

EHA Library, Ran Zhang, 293840

PLASMATIC EXTRACELLULAR VESICLES AND GRAFT VERSUS HOST DISEASE AFTER POST-TRANSPLANT CYCLOPHOSHAMIDE HAPLOIDENTICAL STEM CELL TRANSPLANTATION.

EHA Library, Benedetto Bruno, 293841

IN VITRO INDUCTION AND EXPANSION OF HUMAN CD4+FOXP3+ REGULATORY T CELLS FROM NAÏVE CD4+ T CELLS

EHA Library, Tzeon-Jye Chiou, 293842

THE STUDY ON BAICALIN REGULATES AUTOPHAGY TO PROTECT THE INTESTINAL MUCOSAL BARRIER TO INTERVENTION OF INTESTINAL AGVHD

EHA Library, Xing Cui, 293843

STRATEGY OPTIMIZATION AND CLINICAL STUDY OF MULTIPLE NUCLEOTIDE POLYMORPHISM ANALYSIS IN THE DETECTION OF CHIMERISM AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Zhe Zou, 293844

THE POTENTIAL ROLE OF THROMBOMODULIN GENE POLYMORPHISMS IN THE DEVELOPMENT OF ACUTE GRAFT VERSUS HOST DISEASE AND OUTCOME OF HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Livia Varga, 293845

CYTOMEGALOVIRUS RESULTS IN POOR GRAFT FUNCTION AFTER ALLO-HSCT VIA BONE MARROW STROMAL CELLS：MSCS AND EPCS

EHA Library, Weiran Lv, 293846

UNRAVELING THE EFFECT OF CD34+MICROPARTICLES FROM CORD BLOOD ON APOPTOSIS OF HEMATOPOIETIC CELLS

EHA Library, FANI DELIGIANNI, 293847

MACHINE LEARNING APPLIED TO GENE EXPRESSION SET ANALYSIS PREDICTS ANTI-APOPTOTIC T-CELLS PROFILE THROUGH SERPINB9 AND CDKN2A IN CGVHD.

EHA Library, Juana Serrano Lopez, 293848

UNEXPECTED VARIABILITY OF DONOR CHIMERISM IN PATIENTS FINGERNAILS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION DETECTED BY DIRECT PCR

EHA Library, Ivana Jeziskova, 293849

LABEL-FREE DEEP LEARNING OF NK CELL SUBTYPES WITH SINGLE-CELL IMAGING FLOW CYTOMETRY DATA

EHA Library, Veera Timonen, 293850

MYELOABLATIVE FRACTIONATED BUSULFAN CONDITIONING REGIMEN IN OLDER PATIENTS: RESULTS OF A PHASE II STUDY

EHA Library, Uday R. Popat, 293851

IMPACT OF ANTITHYMOCYTE GLOBULIN DOSE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN STEM CELL TRANSPLANTATION FROM UNRELATED DONORS.

EHA Library, Sara Butera, 293852

MESENCHYMAL STROMAL CELLS DECREASE CHRONIC GRAFT-VERSUS-HOST DISEASE IN MICE AND HUMANS THROUGH RESTORING THYMUS

EHA Library, Ke Zhao, 293853

IMPACT OF SPLEEN SIZE AND SPLENECTOMY ON ALLOGENEIC TRANSPLANTATION OUTCOME IN MYELOFIBROSIS: A RETROSPECTIVE ANALYSIS OF 1196 PATIENTS BY THE CHRONIC MALIGNANCIES WORKING PARTY OF EBMT

EHA Library, Nicola Polverelli, 293854

CYTOTOXICITY OF DONOR NK CELLS TO ALLOREACTIVE T CELLS AREASSOCIATED WITH ACUTE GVHD AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Lixia Sheng, 293855

COMPARISON OF HAPLOIDENTICAL BONE MARROW AND UNRELATED PERIPHERAL BLOOD STEM CELL TRANSPLANTATION BOTH WITH POST TRANSPLANTATION CYCLOPHOSPHAMIDE FOR ACUTE LEUKEMIA: FROM THE ALWP OF THE EBMT

EHA Library, Arnon Nagler, 293856

SEQUENTIAL EUROFLOW MINIMAL RESIDUAL DISEASE (MRD) MONITORING PREDICTS ALLOGENEIC TRANSPLANT OUTCOME IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Joanne Tan, 293857

IN AML THE CLINICAL VALUE OF THE MEASURABLE RESIDUAL DISEASE STATUS BEFORE ALLOGENEIC STEM CELL TRANSPLANTATION DEPENDS ON THE ASSIGNED ELN RISK GROUP

EHA Library, Madlen Jentzsch, 293858

A GUT MICROBIOTA SCORE PREDICTING FOR ACUTE GRAFT-VERSUS-HOST DISEASE FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Lijie Han, 293859

THE MYCOBIOME AFTER FMT FOR INTESTINAL GRAFT-VERSUS-HOST DISEASE

EHA Library, Yannouck van Lier, 293860

MANAGEMENT OF PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA RECEIVING ALLOGENEIC HCT: AN INTERNATIONAL SURVEY ON BEHALF OF THE CHRONIC MALIGNANCIES WORKING PARTY OF EBMT

EHA Library, Francesco Onida, 293861

INTERNATIONAL MULTI-CENTRE RETROSPECTIVE ANALYSIS OF OUTCOMES OF THIOTEPA-BASED AUTOLOGOUS STEM CELL TRANSPLANTATION FOR SECONDARY CNS LYMPHOMA

EHA Library, Jahanzaib Khwaja, 293862

DEFIBROTIDE TREATMENT FOR VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME AFTER HEMATOPOIETIC CELL TRANSPLANTATION: OUTCOMES IN ADULT AND PEDIATRIC PATIENTS FROM AN OBSERVATIONAL REGISTRY STUDY

EHA Library, Mohamad Mohty, 293863

FAVORABLE OUTCOMES AFTER SINGLE CORD BLOOD TRANSPLANTATION FOR PATIENTS WITH HIGH-RISK HEMATOLOGICAL DISEASES: A SINGLE-INSTITUTE RETROSPECTIVE ANALYSIS

EHA Library, Fumiya Wada, 293864

THE 2017 ELN RISK STRATIFICATION FOR ACUTE MYELOID LEUKAEMIA (AML) IS PROGNOSTIC FOR OUTCOMES OF ALLOGENEIC STEM CELL (HSCT).

EHA Library, Yan Beauverd, 293865

KINETICS OF HEMATOLOGIC RECOVERY IN PATIENTS WITH MYELOFIBROSIS UNDERGOING AN ALLOGENEIC HEMOPOIETIC STEM CELL TRANSPLANTATION: THE ROLE OF PATIENT'S AGE AND IMPACT ON MORTALITY

EHA Library, Gabriele Magliano, 293866

SECOND ALLOGENEIC STEM CELL TRANSPLANTATION WITH HAPLOIDENTICAL GRAFTS FOR POST-TRANSPLANT RELAPSE

EHA Library, Samer Srour, 293867

INTENSIFIED MYELOABLATIVE CONDITIONING AGGRAVATES ACUTE GRAFT-VERSUS-HOST DISEASE VIA INFLUENCING INTESTINAL MICROBIOTA IN ALLO-HSCT RECIPIENTS

EHA Library, Lijie Han, 293868

FIRST YEAR REAL-LIFE EXPERIENCE ON CMV PROPHYLAXIS WITH LETERMOVIR IN HIGH-RISK PATIENTS SUBMITTED TO ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Michele Malagola, 293869

ABATACEPT (CTLA4-IG) COMBINED WITH POST TRANSPLANT CYCLOPHOSPHAMIDE (PTCY) AS ACUTE GRAFT VERSUS HOST DISEASE (GVHD) PROPHYLAXIS FOR MATCHED DONOR TRANSPLANTS IN ADULTS WITH LEUKAEMIA AND LYMPHOMA

EHA Library, Amit Patel, 293870

IMPROVED SURVIVAL WITH NON-MYELOABLATIVE ALLOGENEIC TRANSPLANTATION (NMAT) COMPARED TO AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) FOR PATIENTS > 60 YEARS WITH RELAPSED FOLLICULAR LYMPHOMA (FL).

EHA Library, Issa Khouri, 293871

KINETIC PROFILING IDENTIFIES AGE- AND MDS- RELATED CHANGES IN HEMATOPOIETIC STEM AND PROGENITOR CELL DYNAMICS

EHA Library, Michele Buck, 294691

DISTINCT ETHNIC, CLINICAL, AND GENETIC CHARACTERISTICS OF DER(1;7) IN MYELODYSPLASTIC SYNDROMES.

EHA Library, Rurika Okuda, 294692

THE IMPACT OF MICROMEGAKARYOCYTES ON THE MYELODYSPLASTIC SYNDROMES PROGNOSIS

EHA Library, SILVIA SAUMELL, 294693

EFFECT OF LUSPATERCEPT (RAP-536) ON MDS PDX-MURINE MODELS WITH OR WITHOUT SF3B1 MUTATION

EHA Library, Mathieu Meunier, 294694

EVALUATING PATHOGENICITY OF RUNX1 VARIANTS OF UNCERTAIN SIGNIFICANCE BY APPLYING FUNCTIONAL ASSAYS ADDRESSING DIFFERENT MOLECULAR ASPECTS OF THE RUNX1:CBFΒ TRANSCRIPTION FACTOR COMPLEX

EHA Library, Tim Ripperger, 294695

PROMOTER CHROMATIN STATE TRANSITIONS AND TRANSCRIPTIONAL ACTIVITY IN ASXL1-MUTANT CHRONIC MYELOMONOCYTIC LEUKEMIA

EHA Library, Moritz Binder, 294696

LOW IGF1 SIGNALING IN MYELODYSPLASTIC CD34+ HSC IS ASSOCIATED WITH A LEUKEMIC STEM CELL SIGNATURE, REDUCED PROLIFERATIVE ACTIVITY AND POOR PROGNOSIS

EHA Library, Thomas Luft, 294697

INHIBITION OF GLYCOLYSIS IN MYELODYSPLASTIC SYNDROME (MDS): A NOVEL STRATEGY FOR NEW APPROACH FOR THE TARGETED THERAPY OF MDS

EHA Library, Seiichi Okabe, 294698

KER-050, A NOVEL MODIFIED ACTRIIA LIGAND TRAP, INCREASES RED BLOOD CELL PRODUCTION IN CYNOMOLGUS MONKEYS

EHA Library, KEITH BABBS, 294699

IMPACT OF RAS-PATHWAY ACTIVATION ON PHENOTYPE AND OUTCOME IN PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA AND A TET2/SRSF2 COMUTATION

EHA Library, Klaus Geissler, 294700

UPREGULATED HIF-1Α EXPRESSION IN HIGH RISK MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA PATIENTS IS ASSOCIATED WITH BETTER RESPONSE TO AZACITIDINE - DATA FROM THE HELLENIC MDS STUDY GROUP

EHA Library, Vasiliki Pappa, 294701

TP53 STATUS AND OUTCOME IN MYELODYSPLASTIC SYNDROMES WITH COMPLEX ABERRANT KARYOTYPES

EHA Library, Detlef Haase, 294702

KER-050, A NOVEL INHIBITOR OF TGFΒ SUPERFAMILY SIGNALING, INDUCES RED BLOOD CELL PRODUCTION AND IS A POTENTIAL CANDIDATE FOR THE TREATMENT OF INEFFECTIVE HEMATOPOIESIS

EHA Library, Marina Feigenson, 294703

SEVERE ERYTHROID LINEAGE FAILURE DISCRIMINATES RESPONSE AND PROGNOSIS IN MYELODYSPLASTIC SYNDROMES

EHA Library, Huijun Huang, 294704

ATYPICAL DELETIONS OF THE LONG ARM OF CHROMOSOME 5 WITH RETAINED COMMONLY DELETED REGIONS (CDR) IN MDS

EHA Library, Zuzana Zemanova, 294705

BIOENERGETIC ALTERATIONS AS DEFINING FEATURES OF LOW VERSUS HIGH RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Aikaterini Poulaki, 294706

CD3+CD56+ CELLS (TR3-56) AND IMMUNE TOLERANCE CONTROL IN THE BONE MARROW (BM) OF MYELODYSPLASTYC SYNDROME (MDS) INDIVIDUALS.

EHA Library, Stefania Leone, 294707

COMPARISON OF CLINICAL, GENETIC CHARACTERISTICS AND PROGNOSIS OF CMML WITH OR WITHOUT RING SIDEROBLASTS AND MYELODYSPLASTIC SYNDROMES WITH RING SIDEROBLASTS WITH OR WITHOUT MONOCYTOSIS

EHA Library, Blanca Xicoy, 294708

DEFERASIROX-DEPENDENT IRON CHELATION AFFECTS MITOCHONDRIAL DYNAMICS AND STRUCTURE AND RESTORES TP53 FAMILY MEMBERS SIGNALING

EHA Library, Cristina Panuzzo, 294709

DNA REPAIR MECHANISMS IN MYELODYSPLASTIC SYNDROMES (MDS): DIFFERENTIAL GENE EXPRESSION IN MDS SUBTYPES

EHA Library, Stamatina Roussou, 294710

MOLECULAR CHARACTERISTICS THAT PREDICT RESPONSE TO AZACITIDINE THERAPY

EHA Library, Yasuhito Nannya, 294711

THE PROGNOSTIC IMPACT OF CYTOGENETIC SCORES IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROME TREATED WITH VENETOCLAX AND AZACITIDINE IN A PHASE 1 STUDY

EHA Library, Joshua Richter, 294712

ASSESSING THE DETERMINANTS OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES

EHA Library, Igor Stojkov, 294713

MOLECULAR AND CLINICAL FEATURES OF MYELOID NEOPLASMS WITH SOMATIC DDX41 MUTATIONS

EHA Library, Zhijian Xiao, 294714

CLINICAL BENEFIT OF LUSPATERCEPT IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) AND HIGH TRANSFUSION BURDEN (HTB) IN THE PHASE 3 MEDALIST STUDY

EHA Library, Amer M. Zeidan, 294715

DIFFERENCES IN THE GENETIC LANDSCAPE BETWEEN YOUNGER AND OLDER PATIENTS WITH MYELODYSPLASTIC SYNDROME

EHA Library, Wan Hsuan Lee, 294716

COMPARISON BETWEEN UPFRONT TRANSPLANTATION AND CYTOREDUCTIVE THERAPY PRE-TRANSPLANTATION IN PATIENTS WITH MDS-EB-1 OR MDS-EB-2

EHA Library, Yili Chen, 294717

COMBINING FLOW CYTOMETRY, CYTOGENETICS AND MUTATION PROFILING IN PATIENTS WITH IDIOPATHIC CYTOPENIA: AN INTEGRATED PREDICTIVE MODEL

EHA Library, Aref Al-Kali, 294718

REAL-WORLD CLINICAL OUTCOMES IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES TREATED WITH HYPOMETHYLATING AGENTS IN THE US: A SEER-MEDICARE ANALYSIS

EHA Library, Eytan M. Stein, 294719

EVOLUTIONARY ACTION SCORE OF MISSENSE TP53 MUTATIONS (EAP53) IS AN INDEPENDENT PREDICTOR OF SURVIVAL IN MYELODYSPLASTIC SYNDROMES

EHA Library, Rashmi Kanagal-Shamanna, 294720

PROGNOSTIC VALUE OF MONOCYTE SUBSET DISTRIBUTION IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) : RESULTS OF A MULTICENTER STUDY.

EHA Library, Matthieu Jestin, 294721

PROSPECTIVE EVALUATION FOR MYELOID CLONAL EVOLUTION AND ADVERSE CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CLONAL CYTOPENIAS OF UNDETERMINED SIGNIFICANCE (CCUS)

EHA Library, Marissa Li, 294722

ADMINISTRATION OF KER-050, A NOVEL ACTRIIA LIGAND TRAP, TO HEALTHY PARTICIPANTS ELICITED ROBUST AND SUSTAINED INCREASES IN HEMOGLOBIN AND PLATELETS

EHA Library, CLAUDIA ORDONEZ, 294723

EFFECTS OF LUSPATERCEPT ON SERUM FERRITIN IN PATIENTS (PTS) WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (MDS) WITH RING SIDEROBLASTS (RS) IN THE PHASE 3 MEDALIST TRIAL

EHA Library, Pierre Fenaux, 294724

DEVELOPMENT OF GUIDELINE-BASED INDICATORS FOR ADULT PATIENTS WITH MYELODYSPLASTIC SYNDROMES

EHA Library, Nicolas Bonadies, 294725

MOLECULAR BASIS AND CLINICAL IMPLICATION OF SPONTANEOUS IN VITRO MYELOID COLONY FORMATION IN CHRONIC MYELOMONOCYTIC LEUKEMIA

EHA Library, Klaus Geissler, 294726

ROLE AND RATE OF ALLOGENEIC STEM CELL TRANSPLANTATION IN MYELODYSPLASTIC SYNDROMES: DATA FROM THE FISIM REGISTRY

EHA Library, Elena Crisà, 294727

PRACINOSTAT LOWER DOSE PLUS AZACITIDINE SAFETY AND EFFICACY IN PATIENTS WITH HIGH/VERY HIGH-RISK MYELODYSPLASTIC SYNDROMES: A PHASE II STUDY

EHA Library, Michael K. Keng, 294728

ASSESSMENT OF DOSE-DEPENDENT RESPONSE TO LUSPATERCEPT IN PATIENTS (PTS) WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) WITH RING SIDEROBLASTS IN THE PHASE 3 MEDALIST TRIAL

EHA Library, Uwe Platzbecker, 294729

LONGER-TERM RED BLOOD CELL (RBC) TRANSFUSION REDUCTION IN THE PHASE 3 MEDALIST STUDY OF LUSPATERCEPT IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) WITH RING SIDEROBLASTS (RS)

EHA Library, Rami S. Komrokji, 294730

SIGNIFICANT RATE OF PATIENTS WITH MYELODYSPLASTIC SYNDROME FAILING TO REACH ALLOGENIC STEM CELL TRANSPLANTATION: A POPULATION -BASED STUDY

EHA Library, Carolin Lindholm, 294731

PRELIMINARY RESULTS FROM AN OPEN-LABEL, PHASE 2 STUDY OF TIPIFARNIB IN CHRONIC MYELOMONOCYTIC LEUKEMIA, (CMML) AND OTHER MYELODYSPLASTIC /MYELOPROLIFERATIVE NEOPLASIAS (MDS/MPN).

EHA Library, Dr. Mrinal Patnaik, 294732

IMPACT OF ERYTHROPOIETIN STIMULATION AGENTS AND RED BLOOD CELL TRANSFUSION ON HEALTH-RELATED QUALITY OF LIFE IN LOWER-RISK MYELODYSPLASTIC SYNDROME

EHA Library, Hege Gravdahl Garelius, 294733

CONSENSUS SET OF CORE PATIENT-REPORTED OUTCOMES FOR MYELODYSPLASTIC SYNDROMES DEFINED BY PATIENTS AND HEMATOLOGISTS – EUMDS REGISTRY GROUP STUDY

EHA Library, Igor Stojkov, 294734

CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA WHO DEVELOPED THERAPY RELATED MYELOID NEOPLASMS FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION

EHA Library, Fevzi Yalniz, 294735

AZACITIDINE AND LENALIDOMIDE (COMBINED VERSUS SEQUENTIAL TREATMENT) IN HIGHER-RISK MYELODYSPLASTIC SYNDROMES. FINAL RESULTS OF A RANDOMIZED PHASE II MULTICENTER STUDY AND LONG-LASTING RESPONSES

EHA Library, Carlo Finelli, 294736

FACTORS ASSOCIATED WITH RISK OF CARDIOVASCULAR DEATH IN MDS. A NESTED CASE CONTROL STUDY OF 831 PATIENTS OF THE HELLENIC NATIONAL REGISTRY OF MYELODYSPLASTIC AND HYPOPLASTIC SYNDROMES.

EHA Library, Ioannis Kotsianidis, 294737

CUMULATIVE LINES OF PRIOR CHEMOTHERAPY PREDICT OVERALL SURVIVAL IN THERAPY-RELATED MYELODYSPLASTIC SYNDROME (MDS)

EHA Library, Urshila Durani, 294738

THE PROGNOSTIC IMPACT OF MEDULLARY ABNORMALITIES OF THE APPENDICULAR SKELETON DETECTED BY LOW-DOSE MULTIDETECTOR COMPUTED TOMOGRAPHY AND WILMS' TUMOR GENE 1 EXPRESSION LEVELS IN PATIENTS WITH MDS

EHA Library, Kentaro Narita, 294739

CLINICAL ANALYSIS OF GENE MUTATION CHARACTERISTICS AND MUTATION BURDEN IN MYELODYSPLASTIC SYNDROME

EHA Library, Xiaodong Lyu, 294740

EFFECT OF AZACYTIDINE ON SURVIVAL AND LEUKEMIA EVOLUTION IN INTERMEDIATE-RISK MDS: A RETROSPECTIVE COHORT ANALYSIS OF THE HELLENIC NATIONAL REGISTRY OF MYELODYSPLASTIC AND HYPOPLASTIC SYNDROMES.

EHA Library, Ioannis Kotsianidis, 294741

NATURAL HISTORY OF LOWER-RISK MYELODYSPLASTIC SYNDROMES WITH RING SIDEROBLASTS: A RETROSPECTIVE ANALYSIS OF THE CANADIAN MDS-CAN REGISTRY

EHA Library, Heather Leitch, 294742

IVOSIDENIB (IVO) IN PATIENTS WITH IDH1-MUTANT RELAPSED/REFRACTORY MYELODYSPLASTIC SYNDROME (R/R MDS): UPDATED ENROLLMENT OF A PHASE 1 DOSE ESCALATION AND EXPANSION STUDY

EHA Library, Courtney D DiNardo, 294743

THE BURDEN OF RED BLOOD CELL TRANSFUSIONS ON OVERALL SURVIVAL, HEALTHCARE RESOURCE UTILIZATION, AND QUALITY OF LIFE IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES AND RING SIDEROBLASTS

EHA Library, Heather Leitch, 294744

PHASE 3, RANDOMIZED, OPEN-LABEL STUDY OF PEMBROLIZUMAB (PEMBRO) VERSUS BRENTUXIMAB VEDOTIN (BV) FOR TREATMENT OF RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA (R/R CHL): KEYNOTE-204

EHA Library, Pier Luigi Zinzani, 303389